All sites C00-96,D32-33,D42-43,D45-47,D76 159 88.3 3.3 5.4 1.0 2.0
Mouth, pharynx C00-14 4 94.4 - - 5.6 -
  Lip C00 0 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 - - - - - -
  Pharynx C01,C09-14 1 85.7 - - 14.3 -
Digestive organs C15-26 32 91.3 3.8 3.1 0.6 1.3
  Oesophagus C15 3 100.0 - - - -
  Stomach C16 2 100.0 - - - -
  Small intestine C17 1 75.0 25.0 - - -
  Colon C18 8 95.1 - 4.9 - -
  Rectum, rectosigmoid C19-20 6 100.0 - - - -
  Anus C21 1 75.0 - - 25.0 -
  Liver C22 3 100.0 - - - -
  Gallbladder, bile ducts C23-24 3 61.5 23.1 15.4 - -
  Pancreas C25 6 82.1 7.1 3.6 - 7.1
  Other digestive organs C26 0 100.0 - - - -
Respiratory organs C30-39 23 54.3 14.7 27.6 - 3.4
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 22 54.1 15.6 28.4 - 1.8
  Mediastinum, pleura C38 0 50.0 - 50.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 6 96.7 - - 3.3 -
Skin, non-melanoma C44 8 97.4 - - - 2.6
Mesothelioma C45 - - - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 2 90.9 - - - 9.1
Breast C50 0 100.0 - - - -
Male genital organs C60-63 47 98.7 - - 0.4 0.9
  Prostate C61 45 98.7 - - 0.4 0.9
  Testis C62 1 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 17 96.4 - - - 3.6
  Kidney C64 5 92.6 - - - 7.4
  Bladder and urinary tract2 C65-68 11 98.2 - - - 1.8
Eye C69 - - - - - -
Brain, central nervous system C70-72,D32-33,D42-43 4 84.2 - 10.5 - 5.3
Thyroid gland C73 1 66.7 33.3 - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 2 72.7 - 27.3 - -
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 13 86.6 3.0 1.5 6.0 3.0
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 7 97.2 - 2.8 - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 1 57.1 - - 14.3 28.6
  Leukaemia C91-95 4 72.2 11.1 - 16.7 -
  Myelodysplastic syndromes D46 0 100.0 - - - -
  Myeloproliferaitive neoplasms D45,D47 0 100.0 - - - -
Not included above
  Basal cell carcinoma of the skin 54 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.